Russia to begin Phase III trials of second COVID-19 vaccine

world October 03, 2020

Moscow

Russia will begin Phase III trials of a second potential vaccine against COVID-19, developed by Siberia’s Vector Institute, in November-December, the TASS news agency cited Russian consumer safety watchdog Rospotrebnadzor as saying on Friday. Early-stage clinical trials for the vaccine were completed on Wednesday

Russia to begin Phase III trials of second COVID-19 vaccine

One more Corona infected succumbs to death taking death toll to 257

Pompeo says Asia trip next week

Marco Rubio Sworn in as 72nd U.S. Secretary of State

WHO Expresses Regret Over U.S. Decision to Withdraw from Organization

Emmanuel Macron to Deliver Keynote Address at 2025 IISS Shangri-La Dialogue in Singapore

UN Chief Urges Unified Action to Secure Peace Amid Middle East Transformation

‘Dear friend’: Nations react to Trump inauguration

Israel-Hamas truce holding after first hostage-prisoner swap

Fire at Turkish Ski Resort Hotel Claims 10 Lives, Injures 32

Airlines Issue Travel Advisories Ahead of India’s Republic Day Celebrations

Do you know why President Trump withdrew the U.S. from the WHO?

"‘We Are Taking It Back’: Trump Pledges to Reclaim Panama Canal and Protect American Borders

Donald J. Trump Sworn In as 47th President of the United States

Arrest Warrant Issued for Bangladeshi Cricket Star Shakib Al Hasan Over Bounced Cheques

Philippines Secures $15 Billion Renewable Energy Deal with UAE’s Masdar

France Showcases Innovation at Arab Health 2025

India to Extract 6,500 Carats of Diamonds Worth $3.4 Million This Fiscal Year

Djokovic embroiled in media spat as Sinner and Swiatek advance in Australian Open amid heat

Women empowerment must start at home

Strategic Publicity & advertising company W.L.L,

Subscription and Circulation

News Room

Marketing

Russia to begin Phase III trials of second COVID-19 vaccine

Most Read